"The NCI-designated cancer centers program recognizes centers around the country that meet rigorous criteria for world-class, state-of-the-art programs in multidisciplinary cancer research," said Linda K. Weiss, PhD, director of the Office of Cancer Centers of the National Cancer Institute. "These centers including the UCSF Helen Diller Family Comprehensive Cancer Center have dedicated significant resources into developing research programs, faculty and facilities that will lead to better approaches to prevention, diagnosis, and treatment of cancer. The NCI designation not only recognizes excellence but opens doors to greater federal funding, information sharing, and resources."
In the NCI's award notification that touted the center's "complete spectrum of cancer research," the overall quality of research programs was described as "outstanding to excellent."
"The center has developed a solid record of important discoveries in basic, translational, population-based and clinical research," said the NCI. "The strong cancer focus, substantial institutional commitment, and sustained high level of research funding base with a significant number of multi-investigator, team-based programmatic grants have positively influenced the research programs at the center. Clinical translational research has expanded with an increased number of patients enrolled on therapeutic and non-therapeutic clinical trials along with an increased number of investigator-initiated, institutional clinical trials."
Current grant funding to UCSF investigators for cancer research projects from all sources totals more than $246 million annually. This total includes funding from the NCI
|Contact: Elizabeth Fernandez|
University of California - San Francisco